fda ruling on tirzepatide today says shortage of GLP-1 drug is over Drugmakers can keep making off-brand

Clinical Uses: Nausea & vomiting (postoperative, drug-induced, migraine-associated) Diabetic gastroparesis Gastroesophageal reflux disease (GERD) Facilitation of small-bowel intubation Adverse Effects: Extrapyramidal symptoms (EPS) such as dystonia, tremors Drowsiness, restlessness Long-term use Tardive dyskinesia Contraindicated in Parkinsons disease & bowel obstruction Clinical Tip: Use short-term (12 weeks) when possible

Patients receive clear administration instructions, video demonstrations for proper reconstitution, and ongoing monitoring through regular check-ins and follow-up laboratory testing

References Stanley TL, Chen CY, Branch KL, Makimura H, Grinspoon SK

Is this drug better than existing drugs for the actual health issue

either in the form of parenteral artificial nutrition solutions (carbohydrates, amino acids, peptides, lipids, electrolytes, trace elements, vitamins)